INVAInnoviva, Inc.

$1B

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$59M+80.3% YoY

Gross Profit

$58M99.4% margin

Operating Income

$48M81.7% margin

Net Income

$35M60.0% margin

EPS (Diluted)

$0.30

QoQ Revenue Growth

+44.6%

Cash Flow

Operating Cash Flow

$23M

Free Cash Flow

$23M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$372M

Total Liabilities

$669M

Stockholders' Equity

-$297M

Cash & Equivalents

$128M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$59M	$32M	+80.3%
Gross Profit	$58M	$32M	+81.3%
Operating Income	$48M	$26M	+84.8%
Net Income	$35M	$15M	+140.8%

INVA Q2 2017 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena